Biotrin International - Company Logo
 
 
  Actualités
 
18th June 2010Biotrin Group Announce Research and Development project for Dublin with the Creation of 40 new jobs
 

Leading-edge Medical Device investment demonstrates Ireland’s reputation as a key Research and Development Location.

Dublin, Minister for Enterprise, Trade and Innovation, Batt O’Keffe TD, today (18th June 2010) welcomed the announcement by Biotrin, a leading developer and manufacturer of diagnostic platform technology, of an investment in a new Research and Development (R&...  


 
25th March 2010BioMedica Conference, Dublin, Ireland 27th-28th April 2010
 

BioMedica Conference, Dublin, Ireland 27th-28th April 2010

Biotrin will co-exhibit with DiaSorin at the upcoming BioMedica conference which takes place at the RDS, Dublin on 27-28th April 2010.   

Join us at Booth #330, where members of our local and UK team will be on hand to discuss both our newly launched and existing product ranges.

For more detai...  


 
25th March 2010Clinical Virology Symposium, Daytona Beach, Florida USA, April 25-28th 2010
 

Clinical Virology Symposium, Daytona Beach, Florida USA, April 25-28th 2010

Biotrin welcomes you to sunny Florida from April 25th to 28th where we will be exhibiting at the 26th annual Clinical Virology Symposium in Daytona Beach. 

The meeting held at the Hilton Daytona Beach Oceanfront Resort includes an extensive scientific programme of plenary sessions, panel discu...  


 
31st August 2009Important information regarding the detection of the H1N1 (Swine Flu) antigen by the Biotrin Respiratory Virus Panel IFA kit.
 

In the Biotrin RVP kit (code V4RVP) it has been verified that the monoclonal antibodies directed against influenza A have positively detected the new strain of H1N1, most recently known as "swine flu". The new strain was shown to have been detected in both direct specimens and after amplification in culture.

N...  


 
30th June 2009Biotrin Customer Care introduces Online Support form
 

The Biotrin Customer Care Team, dedicated to responding to technical enquiries and observations, has been in place since 2007.

To demonstrate our commitment to improving this service we have made the Customer Care Team more accessible through the introduction of an on-line enquiry form as well as introducing a dedicated Skype account.

The Biotrin C...  


 
1st March 2009Biotrin appoint new General Manager
 

The Company is pleased to announce the appointment of Des O’Leary to the post of General Manager, Biotrin Ltd. 

The appointment is effective from today, March 01st 2009 and he will share his duties with Dr. Cormac Kilty until July 09, when Cormac will leave Biotrin. Des will report directly to the CEO Diasorin S.p.A
Des, who has been with Biotrin since 19...  


 
10th July 2008Diasorin S.p.A, Italy purchase Biotrin Group Ltd
 

 

 

Biotrin, Dublin, Ireland (9th July 2008) has today announced the purchase by DiaSorin S.p.A, Saluggia, Italy, of 100% of the shareholding of Biotrin Group Ltd, held by Dr Cormac Kilty, management and Enterprise Ireland, for a t...  


 
10th July 2008Argutus Medical Limited - new spin out company of Biotrin's biomarker business
 

 

 

Dublin, Ireland (9th July 2008) Dr Cormac Kilty, founder and CEO of Biotrin Group Limited is pleased to announce the successful spin-out of Biotrin’s biomarker of organ damage business into a new company,...  


 
17th January 2008Parvovirus B19 (Fifth disease) storyline to feature in next episode of ER
 

Parvovirus B19 (Fifth Disease) to feature in the next episode of ER click here to find out more

...  

 
13th December 2007Improvement to Biotrin HHV 6 IgG EIA product
 

As part of our continuous improvement service to our customers, we have made the following enhancements to the HHV 6 IgG Enzyme Immunoassay (EIA).

  • Inclusion of LSC – Lot Specific Constant. This number will be a batch specific number and it will be clearly stated inside the kit box lid. We have added an LSC to this product to minimise any lot to lot variation of resu...  

 
1st December 2007Christmas Greetings from Biotrin
 Biotrin wish all their customers a happy Christmas! Click Here...  

 
29th November 2007RVP IFA product update: AD14 detected
 A re emergence of Adenovirus serotype 14 (Ad14) was recently reported in the Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC).

Ad14  was first described in the 1950’s and it is a rarely reported but recently emerging serotype of adenovirus that can cause severe and sometimes fatal respiratory illness in patients of all ag...  

 
14th September 2007Launch of Biotrin RSV Solo
 

Biotrin are pleased to announce the launch of Biotrin RSV Solo, a rapid RSV antigen detection assay for the accurate detection of RSV antigens in respiratory  samples 

Product Codes: V10RSV ( 10 Device Pack)
    &nbs...  


 
13th September 2007Parvovirus B19 IgG EIA Notice
 

Changes have been made to the Instructions for use for the Parvovirus B19 IgG EIA kit. This only effects kit from lot 75KT020 onwards. These changes do not affect the assay procedure. Click here to download the changes

...  

 
13th September 2007Parvovirus B19 IgM EIA Notice
 

Changes have been made to the Instructions for use for the Parvovirus B19 IgG EIA kit. This only effects kit from lot 76KT014 onwards. These changes do not affect the assay procedure. Click here to download the changes


© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity

DiaSorin S.A. Parc de Haute Technologie - Antony 2 11, Rue George Besse 92160 Antony, France.
Tel: +33 1 55590400 Fax: +33 1 55590440
E-mail: Gilles.Augrandjean@Diasorin.it
For technical support please email: customercare@biotrin.ie